The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers
Abstract
In vitro cell lines were established from seven biologically distinct in vivo Dunning R3327 rat prostatic tumor sublines. Some of these in vitro cell lines (i.e., G, AT‐1, AT‐2) retain a low metastatic ability when inoculated back into syngeneic Copenhagen male rats, while others (i.e., AT‐3, MAT‐LyLu, MAT‐Lu) retain a very high metastatic ability. A series of genetic (i.e., DNA content per cell, modal chromosomal number), as well as phenotypic parameters (i.e., morphology, 5α‐reductase, androgen receptor, estrogen receptor) were used to validate that the in vitro cell lines retained the major characteristics of the parental in vivo tumor sublines used for their respective establishment. A series of additional characteristics (i.e., morphology, growth rate, saturation density in surface culture, anchorage‐dependent and ‐independent clonogenic potential) were compared between the high vs. the low metastatic in vitro cell lines to determine if a discriminatory parameter could be identified which reproducibly predicted the metastatic abilities of the particular prostatic cancer cell line. While the combination of the in vitro cell lines and their parental in vivo tumor subline will be a valuable tool for developing methods for predicting metastatic ability of prostate cancers, no single parameter yet measured is entirely successful in making this important distinction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs
Salmon, S. E., Hamburger, A. W., Soehnlen, B., Durie, B. G. M., Alberts, D. S., & Moon, T. E. (1978) · New England Journal of Medicine · doi:10.1056/nejm197806152982401 · Cited by 970
Vindeløv, L. L. (1977) · PubMed · Cited by 487
Vindeløv, L. L. (1977) · Virchows Archiv B Cell Pathology · doi:10.1007/bf02889282 · Cited by 392
Isaacs, J. T., & Coffey, D. S. (1981) · PubMed · Cited by 371
Self-citationRadical Surgery for Prostatic Cancer
WALSH, P. C., & JEWETT, H. J. (1980) · Cancer · doi:10.1002/cncr.1980.45.s7.1906 · Cited by 343
McKeehan, W. L., Adams, P. S., & Rosser, M. P. (1984) · PubMed · Cited by 312
Androgen Receptor Assay with [3H]Methyltrienolone (R1881) in the Presence of Progesterone Receptors*
ZAVA, D. T., LANDRUM, B., HORWITZ, K. B., & MCGUIRE, W. L. (1979) · Endocrinology · doi:10.1210/endo-104-4-1007 · Cited by 227
Isaacs, J. T., Heston, W. D. W., Weissman, R. M., & Coffey, D. S. (1978) · PubMed · Cited by 170
Self-citationIsaacs, J. T., Wake, N., Coffey, D. S., & Sandberg, A. A. (1982) · PubMed · Cited by 165
Self-citationIsaacs, J. T., & Coffey, D. S. (1981) · Endocrinology · doi:10.1210/endo-108-2-445 · Cited by 103
Self-citation
Cited by
A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, F. A., Blumenstein, B. A., Davis, M. A., & Goodman, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908173210702 · Cited by 1,464
Hedgehog signalling in prostate regeneration, neoplasia and metastasis
Karhadkar, S. S., Steven Bova, G., Abdallah, N., Dhara, S., Gardner, D., Maitra, A., Isaacs, J. T., Berman, D. M., & Beachy, P. A. (2004) · Nature · doi:10.1038/nature02962 · Cited by 950
Self-citationMolecular genetics of prostate cancer
Abate-Shen, C., & Shen, M. M. (2000) · Genes & Development · doi:10.1101/gad.819500 · Cited by 735
Human prostate cancer risk factors
Bostwick, D. G., Burke, H. B., Djakiew, D., Euling, S., Ho, S.-M., Landolph, J., Morrison, H., Sonawane, B., Shifflett, T., Waters, D. J., et al. (2004) · Cancer · doi:10.1002/cncr.20408 · Cited by 650
Wu, H., Hsieh, J., Gleave, M. E., Brown, N. M., Pathak, S., & Chung, L. W. K. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570319 · Cited by 499
The Tomato As a Functional Food
Canene-Adams, K., Campbell, J. K., Zaripheh, S., Jeffery, E. H., & Erdman, J. W. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.5.1226 · Cited by 416
Cellular mechanisms of direct-current electric field effects: galvanotaxis and metastatic disease
Mycielska, M. E., & Djamgoz, M. B. A. (2004) · Journal of Cell Science · doi:10.1242/jcs.01125 · Cited by 375
Gagnon, M. L., Bielenberg, D. R., Gechtman, Z., Miao, H.-Q., Takashima, S., Soker, S., & Klagsbrun, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040337597 · Cited by 313
Bielenberg, D. R., Hida, Y., Shimizu, A., Kaipainen, A., Kreuter, M., Kim, C. C., & Klagsbrun, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421378 · Cited by 286
Schempp, C. M., Kirkin, V., Simon-Haarhaus, B., Kersten, A., Kiss, J., Termeer, C. C., Gilb, B., Kaufmann, T., Borner, C., Sleeman, J. P., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205190 · Cited by 269
Autologous Down-Regulation of Androgen Receptor Messenger Ribonucleic Acid
Quarmby, V. E., Yarbrough, W. G., Lubahn, D. B., French, F. S., & Wilson, E. M. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-1-22 · Cited by 268
Abramjuk, C., Jung, K., Krell, H.-W., Juchem, R., Peters, R., Taymoorian, K., Staack, A., Stephan, C., Schnorr, J., Loening, S. A., et al. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000173477.05358.ec · Cited by 7
Metadata
- Authors
- Isaacs, J. T., Isaacs, W. B., Feitz, W. F. J., & Scheres, J.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 1986-01
- Volume
- 9
- Issue
- 3
- Pages
- 261-281
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2057218203
- Cited by
- 407
- References
- 14
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.